Breaking News, Trials & Filings

Trials & Filings: Oct. 22, 2013

Medivation, Astellas, Regeneron

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Phase III EYLEA achieves primary endpoint in BRVO study… read more Medivation, Astellas PREVAIL trial meets co-primary endpoints… read more...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters